Prudential Financial’s Crescent Biopharma CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$307K Buy
+21,032
New +$353K ﹤0.01% 2154

Other funds holding CBIO

Prudential Financial's CBIO Position: Q3 2026 in Review

Prudential Financial opened a new position in Crescent Biopharma (CBIO) in Q3 2026: 21,032 shares worth $307K. The stake represents ﹤0.01% of the portfolio and ranks #2154 among its holdings.

104 funds tracked by Wall St. Rank hold CBIO as of Q3 2026.

  • Prudential Financial held 21,032 shares of Crescent Biopharma worth $307K as of Q3 2026.
  • Crescent Biopharma was a new Prudential Financial position in Q3 2026.
  • Crescent Biopharma made up ﹤0.01% of Prudential Financial's portfolio in Q3 2026, its #2154 holding.
  • 104 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2026.

Based on Prudential Financial's 13F filing for Q3 2026, filed 16 Nov 2026.